Novo Nordisk

Novo Nordisk A/S Almost a third of adults taking Wegovy® pill (oral semaglutide 25 mg) were early responders…

Novo Nordisk has shared new data that suggests a higher dose version of its blockbuster weight loss drug,…

Concerned about an AI bubble? Sign up for The Daily Upside for smart and actionable market news, built…

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St’s investing ideas for…

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St’s investing ideas for…

OTTAWA, May 1 (Reuters) – The ‌Canadian ‌health regulator said on Friday that it had ‌approved Canada-based ⁠Apotex’s…

Novo Nordisk NVO is a dominant player in the GLP-1 space, marketing its semaglutide drugs under brand names Ozempic…

Novo Nordisk NVO and Pfizer PFE are both pharmaceutical giants based in Denmark and the United States, respectively, with…

April 17 (Reuters) – Eli Lilly’s ‌newly launched ‌obesity pill was prescribed 1,390 times in the U.S. as…

Picking winning stocks could lead your portfolio into millionaire territory over time — so it’s important to choose…

HYDERABAD: Soon-to-be brides and grooms seeking shortcuts to shed pounds before the big day have become the latest…

With the expiration of the Canadian patents for weight-loss drugs Ozempic and Wegovy in January, experts are looking…

Wegovy® pill delivered 21.6% weight loss in early responders and doubled mobility improvement, according to new Novo Nordisk data at ECO2026